Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Immunovaccine, Leidos Expand Collaboration to Develop Malaria Vaccines | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Immunovaccine, Leidos Expand Collaboration to Develop Malaria Vaccines

This comes after the successful achievement of preclinical milestones

By: Betsy Louda

, Contract Pharma

Immunovaccine Inc., a clinical stage immunotherapy and vaccine company, is expanding its collaboration with Leidos to develop preventative malaria vaccine candidates.

 

The U.S. Agency for International Development (USAID) supported the collaboration from the start, providing a sub-contract to Leido’s malaria vaccine development program. After that collaboration resulted in several preclinical milestones, Leidos and USAID have now chosen the DepoVax-based platform for further development under a new contract extension The extension aims to evaluate malaria vaccine candidates in the preclinical, clinical, and field stages of development. Research performed under the collaboration with Immunovaccine showed that DepoVax-formulated vaccine candidates comprised of promising T and B cell targets demonstrated protection against the malaria parasite delivered by mosquito bites.

 

“We are very encouraged by what Immunovaccine and Leidos have together accomplished through this collaboration thus far,” said Frederic Ors, chief executive officer of Immunovaccine. “The intrinsic mechanism of action that underscores DepoVax has continued to demonstrate the ability to create targeted immune responses across a broad range of difficult diseases.”




 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics